Other mechanisms have been suggested for the OME antitumor effect, such as reduction of Bcl-2 [174–176], Bcl-xL, and survivin [176], as well as reduction of other antiapoptotic proteins [177, 178]. This evidence concerns the gene BCL2 and otitis media with effusion.